| Date Filed | Type | Description |
| 03/03/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 02/27/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 02/01/2023 |
8-K
| Quarterly results |
| 02/01/2023 |
8-A12G
| Form 8-A12G - Registration of securities [Section 12(g)]: |
| 01/20/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
| 11/28/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 11/18/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 11/15/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/04/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
| 11/04/2022 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 10/28/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 10/27/2022 |
8-K
| Quarterly results |
| 10/24/2022 |
8-K
| Quarterly results |
| 10/21/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 10/17/2022 |
8-K
| Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; T... |
| 10/05/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 09/27/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 08/03/2022 |
8-K
| Changes in Registrant's Certifying Accountant, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 06/22/2022 |
8-K
| Quarterly results |
| 06/06/2022 |
8-K
| Quarterly results |
| 05/27/2022 |
8-K
| Quarterly results |
| 04/27/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/18/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 04/15/2022 |
8-K
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits Interactive Data |
| 04/13/2022 |
8-K/A
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 03/31/2022 |
8-K
| Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran... |
| 03/31/2022 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 03/25/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 03/23/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 03/22/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 03/22/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 03/21/2022 |
3
| Chandrasekhar Satishchandran (Director) has filed a Form 3 on Statera Biopharma, Inc. |
| 03/08/2022 |
8-K/A
| Quarterly results |
|